These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 22585593

  • 21. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

  • 22. Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
    Garcia-Barceló MM, Lam LC, Ungvari GS, Lam VK, Tang WK.
    J Neural Transm (Vienna); 2001 Aug; 108(6):671-7. PubMed ID: 11478419
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility.
    Ivanova SA, Toshchakova VA, Filipenko ML, Fedorenko OY, Boyarko EG, Boiko AS, Semke AV, Bokhan NA, Aftanas LI, Loonen AJ.
    World J Biol Psychiatry; 2015 Apr; 16(3):200-5. PubMed ID: 25602162
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.
    Zai CC, Romano-Silva MA, Hwang R, Zai GC, Deluca V, Müller DJ, King N, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Kennedy JL.
    Schizophr Res; 2008 Dec; 106(2-3):248-52. PubMed ID: 18838251
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
    Matsumoto C, Shinkai T, Hori H, Ohmori O, Nakamura J.
    Psychiatry Res; 2004 Jun 30; 127(1-2):1-7. PubMed ID: 15261699
    [Abstract] [Full Text] [Related]

  • 29. [Study of the prevalence of tardive dyskinesia among psychiatric inpatients].
    Zhang LD.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Aug 30; 21(4):232-5, 255-6. PubMed ID: 2906854
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A, Braus DF, Büchel C, Krumm B, Medori R, Gattaz WF.
    Psychiatr Prax; 2003 Sep 30; 30(6):333-7. PubMed ID: 12970819
    [Abstract] [Full Text] [Related]

  • 32. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
    Pae CU, Kim TS, Patkar AA, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH.
    Psychiatry Res; 2007 Sep 30; 153(1):77-81. PubMed ID: 17582511
    [Abstract] [Full Text] [Related]

  • 33. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM.
    J Clin Psychiatry; 2004 Sep 30; 65 Suppl 9():16-20. PubMed ID: 15189107
    [Abstract] [Full Text] [Related]

  • 34. Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
    Novak G, Gallo A, Zai CC, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN, Remington G, Kennedy JL, Levesque D, Le Foll B.
    Psychiatr Genet; 2010 Feb 30; 20(1):39-43. PubMed ID: 20010315
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tardive dyskinesia and glucid metabolism.
    Brousse G, Meary A, Mouret J, Blanc O, Hueber T, Lemoine P, Llorca PM, Lachaux B.
    Hum Psychopharmacol; 2007 Aug 30; 22(6):373-80. PubMed ID: 17579925
    [Abstract] [Full Text] [Related]

  • 37. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME, DeWolfe AS, Mosnaim AD.
    Hillside J Clin Psychiatry; 1987 Aug 30; 9(1):3-11. PubMed ID: 2888712
    [Abstract] [Full Text] [Related]

  • 38. Tardive dyskinesia in chronic schizophrenic inpatients.
    Kua EH, Ang PC, Siew HC.
    Singapore Med J; 1982 Feb 30; 23(1):19-21. PubMed ID: 6126008
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson's disease and schizophrenia.
    Hong CJ, Liu HC, Liu TY, Liao DL, Tsai SJ.
    J Neural Transm (Vienna); 2005 Nov 30; 112(11):1503-10. PubMed ID: 15719154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.